Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
China Isotope & RadiationHKSE:01763 -0.12%92 Net Margin % is 3.59% as of Dec. 2025, which is 44% below its 10-year median of 6.45. GuruFocus rates HKSE:01763 with a GF Score™ of 92/100 and a GF Value™ of HK$15.75 (Fairly Valued). The stock has 5 warning signs investors should review. Among 815 Medical Devices & Instruments companies, China Isotope & Radiation ranks better than 55.09% on this metric.
The historical rank and industry rank for China Isotope & Radiation's Net Margin % or its related term are showing as below:
HKSE:01763'
s Net Margin % Range Over the Past 10 Years
Min: 4.55 Med: 6.45 Max: 11.09
Current: 4.55
HKSE:01763's Net Margin % is ranked better than 55.09% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 2.2
vs HKSE:01763: 4.55
China Isotope & Radiation (HKSE:01763) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
China Isotope & Radiation Net Margin % Related Terms
China Isotope & Radiation Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01763 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, China Isotope & Radiation's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Isotope & Radiation Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's Net Margin % distribution charts can be found below:
* The bar in red indicates where China Isotope & Radiation's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Isotope & Radiation (HKSE:01763) has a Net Margin % of 3.59% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on China Isotope & Radiation and its competitors. This is 44% below median its historical median of 6.45. Over the past decade, China Isotope & Radiation's Net Margin % has ranged from 4.55 to 11.09. According to the industry distribution chart, China Isotope & Radiation ranks #366 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 44.9%.
Is China Isotope & Radiation's Net Margin % too high?
China Isotope & Radiation's current Net Margin % of 3.59% is 44% below median its 10-year median of 6.45. Over the past 10 years, this metric has ranged from a low of 4.55 to a high of 11.09. The Medical Devices & Instruments industry median Net Margin % is 2.20. China Isotope & Radiation's value of 3.59% is 63.2% above this industry median. Based on the distribution chart, China Isotope & Radiation ranks #366 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, China Isotope & Radiation has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does China Isotope & Radiation's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, China Isotope & Radiation ranks #366 out of 815 companies for Net Margin %. This puts China Isotope & Radiation in the upper half of its industry. The industry median Net Margin % is 2.20. China Isotope & Radiation's value of 3.59% is 63.2% above this benchmark. Historically, China Isotope & Radiation's own Net Margin % has ranged from 4.55 to 11.09 over the past decade. While the company's 10-year median is 6.45 vs. the industry median of 2.20, China Isotope & Radiation has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.20, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Isotope & Radiation's current Net Margin % of 3.59% is 63.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on China Isotope & Radiation and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Isotope & Radiation's current Net Margin % is 3.59%, which is 44% below median its own 10-year median of 6.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Isotope & Radiation stock overvalued right now?
Based on GuruFocus' analysis, China Isotope & Radiation (HKSE:01763) is currently considered Fairly Valued. The stock's GF Value™ is HK$15.75, compared to a current price of HK$17.00 — trading 7.9% above its estimated fair value. The current Net Margin % is 3.59%, which is 44% below median its 10-year median of 6.45 and 63.2% above the Medical Devices & Instruments industry median of 2.20. China Isotope & Radiation's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For China Isotope & Radiation (HKSE:01763), the current Net Margin % is 3.59% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Isotope & Radiation (HKSE:01763) Overvalued in 2026?
Based on GuruFocus' analysis, China Isotope & Radiation stock appears to be overvalued.
The current stock price of HK$17.00 is trading 7.9% above its estimated GF Value™ of HK$15.75.
GuruFocus considers China Isotope & Radiation to be Fairly Valued.
Key valuation signals for HKSE:01763:
Net Margin %: 3.59% (44% below median its 10-year median of 6.45)
GF Value™: HK$15.75 vs. price of HK$17.00 (7.9% above fair value)
Industry Position: 63.2% above the Medical Devices & Instruments median (#366 of 815)
No single metric tells the full story. See the HKSE:01763 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: (1) nuclear medicine; (2) radioactive source products; (3) irradiation; (4) nuclear medical equipment and related services; and (5) other businesses. Nuclear medicines: manufacturing and sale of a range of imaging diagnostic and therapeutic radio pharmaceuticals imaging, UBT diagnostic kits and test analysers and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The company's operations are carried out and a majority of its customers are located in the PRC.
92GF Score
Get the complete analysis for HKSE:01763
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01763 has been successfully added to your 
